Neisseria meningitidis with reduced sensitivity to penicillin: observations in 10 children. 1991

S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
Hospital de Terrassa, Barcelona, Spain.

10/84 strains (11.9%) of Neisseria meningitidis isolated from blood and/or cerebrospinal fluid in children 1986-1987 had reduced sensitivity to benzylpenicillin (MICs 0.1-0.4 mg/l). Group C meningococci predominated among these strains. The clinical course was satisfactory in all cases regardless of the antibiotic treatment used, although the time to abatement of fever was prolonged compared to that of children infected with susceptible strains.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D008589 Meningococcal Infections Infections with bacteria of the species NEISSERIA MENINGITIDIS. Meningococcal Septicemia,Infections, Meningococcal,Meningococcal Disease,Infection, Meningococcal,Meningococcal Diseases,Meningococcal Infection,Septicemia, Meningococcal
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D010400 Penicillin G A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin Grünenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
August 1988, Anales espanoles de pediatria,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
September 1988, Medicina clinica,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
September 1988, Medicina clinica,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
July 1971, The American journal of the medical sciences,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
January 2002, Revista da Associacao Medica Brasileira (1992),
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
April 1992, Enfermedades infecciosas y microbiologia clinica,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
January 1964, Antimicrobial agents and chemotherapy,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
January 2001, Lijecnicki vjesnik,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
March 2001, The Journal of antimicrobial chemotherapy,
S Uriz, and V Pineda, and M Grau, and J M Nava, and F Bella, and M A Morera, and D Fontanals, and B Font, and C Martí, and F Deulofeu
August 1993, Canada communicable disease report = Releve des maladies transmissibles au Canada,
Copied contents to your clipboard!